Biovail Launches Ralivia? To Canadian Physicians

Biovail Corporation (NYSE:BVF)(TSX:BVF) announced that Ralivia?, the Company’s once-daily tramadol formulation, has been officially launched in Canada, and is now commercially available. Ralivia? is indicated for the management of pain of moderate severity in patients who require continuous treatment for several days or more. [click link for full article]

More: continued here

Filed under: Pain / Anesthetics on November 7th, 2007